Literature DB >> 1122295

The two human chymotrypsinogens. Purification and characterization.

A De Caro, C Figarella, O Guy.   

Abstract

The two chymotrypsinogens present in human pancreatic juice have been purified and characterized. The zymogens are two immunologically and electrophoretically different proteins. Chymotrypsinogen A, the major chymotryptic component (90% of the total potential N-acetyl-L-tyrosine ethylester activity) is stable in acidic medium. By its molecular weight (approx. 24 000), specific activity (530) and amino acid composition, human chymotrypsinogen A resembles chymotrypsinogens A and B form bovine and porcine pancreas. Chymotrypsinogen B is a minor chymotryptic component (7% of the total potential N-acetyl-L-tyrosine ethylester activity) unstable in acidic medium with a molecular weight slightly higher (approx. 27 000) and a specific activity slightly lower (300) than chymotrypsinogen A. The last 3% of the total potential N-acetyl-L-tyrosine ethylester activity corresponds to a proelastase that we have partially characterized.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1122295     DOI: 10.1016/0005-2795(75)90150-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Genomic cloning and partial characterization of human chymotrypsinogen gene.

Authors:  D X Hou; K Ozawa; N Tomita; Y Maeda; T Hashiguchi; K Yokoyama; E Soeda
Journal:  Jpn J Hum Genet       Date:  1993-12

2.  Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein.

Authors:  G Montalto; J Bonicel; L Multigner; M Rovery; H Sarles; A De Caro
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

3.  Immunocytochemical localization of pancreatic carboxylic ester hydrolase in human paneth cells.

Authors:  P Lechene de la Porte; H Lafont; D Lombardo
Journal:  Histochemistry       Date:  1986

4.  The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth.

Authors:  A De Caro; L Multigner; H Lafont; D Lombardo; H Sarles
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

5.  Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.

Authors:  D Belorgey; S Dirrig; M Amouric; C Figarella; J G Bieth
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.